P395 Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease
暂无分享,去创建一个
N. Harpaz | W. Reinisch | B. Feagan | P. Pollack | F. Magro | G. Hertogh | R. Pai | N. Agada | M. Protic | L. S. Chan